Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 67Other hematologic neoplasm 60Myeloid 48Plasma cell 46Sarcoma 23Dermatologic 22Classical hematology 17Genitourinary 5Other neoplasm 4Breast 1

Conditions

Breast Neoplasms 8Triple Negative Breast Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Fallopian Tube Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1Breast Neoplasms, Male 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Therapeutics 6Cyclophosphamide 6Flow Cytometry 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Filgrastim 4pembrolizumab 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Nivolumab 3Immunoenzyme Techniques 3Blood Specimen Collection 3sargramostim 2liposomal amphotericin B 2durvalumab 2copanlisib 2belinostat 2aldesleukin 2Vorinostat 2Surveys and Questionnaires 2Stem Cell Factor 2Rituximab 2Ondansetron 2Methylprednisolone 2Melphalan 2Itraconazole 2Ipilimumab 2Immunologic Techniques 2Gemcitabine 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Cyclosporine × Breast × Clear all
NCT00365287 2017-11-29

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Masonic Cancer Center, University of Minnesota

Phase 1/2 Completed
148 enrolled
BreastClassical hematologyGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡